 NOTE: Eligibility will be confirmed and participants registered on 2 separate, serial occasions on this trial: 1. Initial Study Screening: Shortly after initial resection, newly diagnosed patient is identified and screened. Once overall trial eligibility is confirmed and participant is registered to study, the creation of the participants vaccine is initiated. 2. Secondary Screening: As participants 1st study vaccine dose may not be administered until 10-17 weeks from initial study registration, there will be a secondary screen conducted after participant has completed RT and hisher vaccines have been prepared, to ensure she meets criteria to receive study treatment. If confirmed eligible for this next phase of the study eligible to treat, participant will proceed to receive vaccines on study. 